AOTI (AOTI) H2 2025 TU earnings summary
Event summary combining transcript, slides, and related documents.
H2 2025 TU earnings summary
23 Feb, 2026Executive summary
Achieved FY 2025 revenue growth of approximately 14% to $66.5 million, in line with consensus expectations.
Adjusted EBITDA margin and operational progress reported despite US healthcare market headwinds.
Organisational and operational changes implemented, improving focus on patient outcomes and sales rep productivity.
Anticipates a CMS local coverage determination in the near term, which could be transformational.
Financial highlights
FY 2025 revenue reached about $66.5 million, up from $58.4 million in 2024.
Adjusted EBITDA margin in line with consensus (consensus: 10.8%).
Net debt increased to $6.5 million from net cash of $0.9 million in 2024, but better than consensus expectations.
Arizona Medicaid contributed approximately $9.2 million in revenue for 2025.
Outlook and guidance
Well positioned to re-accelerate growth as US healthcare headwinds abate.
Expects CMS local coverage determination soon, with potential for significant impact.
Sufficient cash generation and headroom in loan facility to support ongoing working capital needs.
Latest events from AOTI
- 26.4% revenue growth, margin gains, and IPO proceeds drive expansion and debt reduction.AOTI
H1 202420 Jan 2026 - Revenue up 32.9% to $58.4M, with margin gains and expanded Medicaid access.AOTI
H2 20247 Jan 2026 - H1 2025 revenue up 20.9% to $31.8m, with Medicaid and VA growth and key global validation milestones.AOTI
H1 202517 Dec 2025 - Revenue up 26.5% in H1 2024; full-year growth above 30% expected after strong Q2.AOTI
H1 2024 TU6 Oct 2025 - Revenue up 32% to $58.1m, margins and growth outlook strong with new market expansion.AOTI
H2 2024 TU6 Oct 2025 - H1 2025 revenue up 18%, outlook trimmed amid US healthcare disruption; Medicaid access expands.AOTI
H1 2025 TU6 Oct 2025